Table 1 Molecular docking with COX11 based on cMAP-predicted high relevance score drug information (TOP4).

From: Exploring biomarkers and molecular mechanisms of Type 2 diabetes mellitus promotes colorectal cancer progression based on transcriptomics

Name

Score

ID

Description

Vina score

Docking size

JNJ-16259685

-99.27

BRD-K64670467

Glutamate receptor antagonist

-6.2

23, 23, 23

Topotecan

-99.22

BRD-A59985574

Topoisomerase inhibitor

-7.3

24, 24, 24

Mocetinostat

-98.72

BRD-K16485616

HDAC inhibitor

-8

27, 27, 27

Aristolochic-acid

-98.62

BRD-K17110974

Phospholipase inhibitor

-6

20, 20, 20